Evidence map›Paper›PMID 30814299›Full record

ArticleThe Journal of experimental medicine2019

Antigen-presenting ILC3 regulate T cell-dependent IgA responses to colonic mucosal bacteria.

Felipe Melo-Gonzalez, Hana Kammoun, Elza Evren, Emma E Dutton, Markella Papadopoulou, Barry M Bradford, Ceylan Tanes, Fahmina Fardus-Reid, Jonathan R Swann, Kyle Bittinger and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 145 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Effects ofFrontiers in veterinary science · 2025
    Article
  12. Article
  13. Article
  14. Group 3 innate lymphoid cells in intestinal health and disease.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 4 countries.

Felipe Melo-GonzalezLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
Hana KammounCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Elza EvrenCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-5656-4417
Emma E DuttonInstitute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID 0000-0003-3677-457X
Markella PapadopoulouLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.ORCID 0000-0002-2764-3474
Barry M BradfordThe Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Easter Bush, UK.ORCID 0000-0002-4007-1685
Ceylan TanesDivision of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA.ORCID 0000-0002-5823-4059
Fahmina Fardus-ReidDivision of Integrative Systems Medicine and Digestive Diseases, Imperial College London, South Kensington, UK.
Jonathan R SwannDivision of Integrative Systems Medicine and Digestive Diseases, Imperial College London, South Kensington, UK.ORCID 0000-0002-6485-4529
Kyle BittingerDivision of Gastroenterology, Hepatology, and Nutrition, The Children's Hospital of Philadelphia, Philadelphia, PA.
Neil A MabbottThe Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Easter Bush, UK.ORCID 0000-0001-7395-1796
Bruce A VallanceDepartment of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, Canada.ORCID 0000-0003-1345-6747
Tim WillingerCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
David R WithersInstitute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID 0000-0003-3757-7594
Matthew R HepworthLydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK matthew.hepworth@manchester.ac.uk.ORCID 0000-0002-9613-7858
Karolinska Institutet · SEManchester Academic Health Science Centre · GBChildren's Hospital of Philadelphia · USImperial College London · GBRoslin Institute · GBUniversity of Birmingham · GBUniversity of British Columbia · CA

Funding

Biotechnology and Biological Sciences Research Council BB/F019726/1Biotechnology and Biological Sciences Research Council BBS/E/D/20002174Medical Research Council MR/L011840/1Wellcome Trust 110199/Z/15/Z
6 · The paper itself

Abstract

Intestinal immune homeostasis is dependent upon tightly regulated and dynamic host interactions with the commensal microbiota. Immunoglobulin A (IgA) produced by mucosal B cells dictates the composition of commensal bacteria residing within the intestine. While emerging evidence suggests the majority of IgA is produced innately and may be polyreactive, mucosal-dwelling species can also elicit IgA via T cell-dependent mechanisms. However, the mechanisms that modulate the magnitude and quality of T cell-dependent IgA responses remain incompletely understood. Here we demonstrate that group 3 innate lymphoid cells (ILC3) regulate steady state interactions between T follicular helper cells (TfH) and B cells to limit mucosal IgA responses. ILC3 used conserved migratory cues to establish residence within the interfollicular regions of the intestinal draining lymph nodes, where they act to limit TfH responses and B cell class switching through antigen presentation. The absence of ILC3-intrinsic antigen presentation resulted in increased and selective IgA coating of bacteria residing within the colonic mucosa. Together these findings implicate lymph node resident, antigen-presenting ILC3 as a critical regulatory checkpoint in the generation of T cell-dependent colonic IgA and suggest ILC3 act to maintain tissue homeostasis and mutualism with the mucosal-dwelling commensal microbiota.

Indexed as

AnimalsAntigen PresentationAntigen-Presenting CellsBacteriaB-LymphocytesColonFemaleGastrointestinal MicrobiomeHelicobacterHistocompatibility Antigens Class IIHomeostasisImmunoglobulin AIntestinal MucosaMaleMiceMice, Inbred C57BLHistocompatibility Antigens Class IIImmunoglobulin A

Identifiers

PMID30814299
PMCPMC6446868
OpenAlexW2913734302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.